Interventional experiments using the SHH pathway activator (SAG) on MORF4L1-knockdown cells restored spheroid formation capacity and in vivo tumorigenicity, establishing MORF4L1’s pivotal role in HCC stemness through the Hedgehog pathway activation (Figs. 8E–J). This evidence concerns the gene MORF4L1 and hepatocellular carcinoma.